NeuroOne Medical Technologies Price to Book Ratio 2021-2024 | NMTC
Historical price to book ratio values for NeuroOne Medical Technologies (NMTC) over the last 10 years. The current price to book ratio for NeuroOne Medical Technologies as of May 05, 2025 is 6.58.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| NeuroOne Medical Technologies Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-05-05 | 0.64 | 6.70 | |
| 2024-12-31 | 0.83 | $0.10 | 8.68 |
| 2024-09-30 | 0.99 | $0.03 | 37.08 |
| 2024-06-30 | 0.80 | $0.11 | 7.39 |
| 2024-03-31 | 1.20 | $0.15 | 8.20 |
| 2023-12-31 | 1.58 | $0.18 | 8.88 |
| 2023-09-30 | 0.89 | $0.26 | 3.41 |
| 2023-06-30 | 1.20 | $0.22 | 5.47 |
| 2023-03-31 | 1.61 | $0.33 | 4.91 |
| 2022-12-31 | 1.20 | $0.50 | 2.38 |
| 2022-09-30 | 1.69 | $0.59 | 2.85 |
| 2022-06-30 | 0.82 | $0.66 | 1.25 |
| 2022-03-31 | 1.10 | $0.81 | 1.36 |
| 2021-12-31 | 1.94 | $0.99 | 1.97 |
| 2021-09-30 | 3.95 | $0.55 | 7.24 |
| 2021-06-30 | 6.63 | $0.74 | 8.97 |
| 2021-03-31 | 7.35 | $0.91 | 8.06 |
| 2020-12-31 | 4.71 | 0.00 | |
| 2020-09-30 | 3.86 | 0.00 | |
| 2020-06-30 | 4.29 | 0.00 | |
| 2020-03-31 | 5.64 | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.030B | $0.003B |
| NeuroOne Medical Technologies Corporation is a medical technology company. It focused on improving surgical care options and outcomes for patients suffering from neurological disorders. NeuroOne Medical Technologies Corporation is based in EDEN PRAIRIE, Minn. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.454B | 26.72 |
| Elevance Health (ELV) | United States | $92.629B | 11.95 |
| CVS Health (CVS) | United States | $85.338B | 10.61 |
| Cencora (COR) | United States | $56.647B | 20.56 |
| Natera (NTRA) | United States | $21.178B | 0.00 |
| DiDi Global (DIDIY) | China | $19.767B | 30.00 |
| BioMerieux (BMXMF) | France | $15.407B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.351B | 0.00 |
| Solventum (SOLV) | United States | $11.698B | 10.91 |
| CochLear (CHEOY) | Australia | $11.662B | 0.00 |
| ICON (ICLR) | Ireland | $11.545B | 10.73 |
| Revvity (RVTY) | United States | $11.293B | 19.07 |
| Doximity (DOCS) | United States | $11.076B | 57.60 |
| Viatris (VTRS) | United States | $10.258B | 3.26 |
| Avantor (AVTR) | United States | $8.770B | 12.74 |
| Medpace Holdings (MEDP) | United States | $8.769B | 23.29 |
| Sonic Healthcare (SKHHY) | Australia | $8.097B | 0.00 |
| HealthEquity (HQY) | United States | $7.835B | 38.54 |
| Charles River Laboratories (CRL) | United States | $5.818B | 11.48 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.064B | 23.96 |
| BrightSpring Health Services (BTSG) | United States | $3.654B | 33.66 |
| Sotera Health (SHC) | United States | $3.514B | 19.97 |
| Alignment Healthcare (ALHC) | United States | $3.073B | 0.00 |
| Surgery Partners (SGRY) | United States | $2.959B | 33.94 |
| Concentras Parent (CON) | United States | $2.792B | 14.52 |
| Organon (OGN) | United States | $2.493B | 2.65 |
| Progyny (PGNY) | United States | $1.990B | 43.83 |
| GeneDx Holdings (WGS) | United States | $1.887B | 73.88 |
| Ardent Health Partners (ARDT) | United States | $1.880B | 0.00 |
| Premier (PINC) | United States | $1.868B | 11.97 |
| GoodRx Holdings (GDRX) | United States | $1.795B | 39.00 |
| Agilon Health (AGL) | United States | $1.718B | 0.00 |
| PACS (PACS) | United States | $1.535B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.239B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.110B | 9.31 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.039B | 0.00 |
| Establishment Labs Holdings (ESTA) | $0.963B | 0.00 | |
| CareDx (CDNA) | United States | $0.835B | 13.04 |
| AMN Healthcare Services Inc (AMN) | United States | $0.811B | 6.42 |
| Embecta (EMBC) | United States | $0.740B | 5.07 |
| Nutex Health (NUTX) | United States | $0.634B | 12.42 |
| QDM (QDMI) | Hong Kong, SAR China | $0.583B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.512B | 13.57 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.426B | 0.00 |
| Enhabit (EHAB) | United States | $0.408B | 38.33 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.389B | 0.00 |
| SBC Medicals (SBC) | United States | $0.321B | 0.00 |
| LifeMD (LFMD) | United States | $0.319B | 0.00 |
| DocGo (DCGO) | United States | $0.236B | 9.62 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.196B | 0.00 |
| Beauty Health (SKIN) | United States | $0.143B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.110B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.087B | 0.00 |
| So-Young (SY) | China | $0.085B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.077B | 0.00 |
| Biodesix (BDSX) | United States | $0.076B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.065B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| ModivCare (MODV) | United States | $0.021B | 7.30 |
| KindlyMD (KDLY) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |